Use of Brilliant Blue G in Descemet’s Membrane Endothelial Keratoplasty

Table 1

Patient data.

Case	Sex	Age (years)	OD/OS	Etiology; of BK	Preop.; BSCVA	Preop.; CCT (μm)	Postop.; BSCVA	Postop.; CCT (μm)	Staining capacity
()	F	71	OS	LI	20/60	712	20/15	565	S
()	M	79	OS	PEX	20/400	737	20/30	598	S
()	F	74	OD	PEX	20/60	698	20/25	531	S
()	M	69	OS	PBK	20/30	604	20/15	456	S
()	F	73	OD	FCED	20/400	744	20/25	446	S
()	F	78	OD	LI	20/100	763	20/15	473	S
()	F	81	OS	LI	20/1000	652	20/20	520	S
()	F	78	OS	LI	20/60	771	20/20	570	S
()	F	70	OD	FCED	20/60	744	20/20	491	S
()	F	83	OD	PBK	20/600	708	20/20	512	S
()	F	74	OS	LI	20/2000	834	20/25	510	S
()	F	81	OD	PBK	20/400	676	20/20	509	S

OD, right eye; OS, left eye; preop., preoperative; postop., postoperative; BSCVA, best-corrected scale-corrected visual acuity; CCT, central corneal thickness; BK, bullous keratopathy; PEX, pseudoexfoliation syndrome; FCED, Fuchs’ corneal endothelial dystrophy; LI, laser iridectomy; staining capacity was scored as follows: W, worse than trypan blue (TB); S, similar to TB; and B, better than TB.